Positive high-level results from the Phase III KALOS and LOGOS trials in patients with uncontrolled asthma showed that AstraZeneca’s fixed-dose triple-combination therapy BREZTRI AEROSPHERE ...

AmacaThera, a clinical-stage biotechnology company specializing in drug delivery, announced it has signed a binding ...

AstraZeneca announced on Friday that its inhaled triple-combination therapy ‘Breztri Aerosphere’ met all primary endpoints in ...

Ipsen Biopharmaceuticals Canada Inc. today announced Health Canada has issued a Notice of Compliance with Conditions (NOC/c) ...

"We found that some cancer types responded extremely well to the immunotherapy, including colon and stomach cancer," ...

The anti-science policies of Trump and Robert F. Kennedy are aiding the spread of long-suppressed childhood diseases.

The Cambridge, England-based pharmaceutical company said its Kalos and Logos phase 3 trials showed Breztri achieved statistically significant and clinically meaningful improvements in lung function ...

By granting creators and inventors exclusive rights to their work, IP laws provide a powerful incentive for individuals and ...

President Donald Trump told reporters that he recently pressed Israeli Prime Minister Benjamin Netanyahu on allowing more aid ...

Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, Telix, the Company) today announces that its prostate cancer PET[1] ...

New approval provides French hospitals and clinics with access to a proven PSMA-PET imaging agent MELBOURNE, Australia, April 29, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: ...

The proton beam therapy center will be Penn's fourth when it opens in late 2027. The others are at HUP, Virtua Voorhees, and ...